Search results for: Multi-Indication Medicines
Filter search results
Measuring the Benefits of Medicines: The Future Agenda
1 March 1990
…of cost effectiveness in medical care. Now in 1990 the industry is still ahead in undertaking economic analyses to demonstrate the fact that its medicines are often the most economical…
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
…perspective of the experience of the economic regulation of other industries in the UK, notably the privatised utilities. Share this: Download publication The NHS procures medicines in a variety of…
Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study
1 January 2017
…framework for developing medicines formularies which combines macro-level decision… PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for…
Policy Options for Formulary Development in Middle-income Countries
1 January 2017
…medicines for formulary inclusion. This report presents a framework for developing medicines formularies which combines macro-level decision making factors (focusing on the health system organisation and its priority setting), and…
Victoria Jordan
21 January 2026
…in Economic Evaluation for HTA, Health Economics from the University of York and enjoys bringing together advances in medicines evaluation methods and processes with the practicalities of getting new medicines…
Capturing the lived experiences of informal care in acute leukemia
20 November 2025
Share this: Download publication Samantha Nier Claud Theakston Priscila Radu David Mott Nadine Henderson Key takeaways Providing informal care to someone living with acute leukemia imposes a severe multidimensional burden,…
Addressing the systemic challenges of underinvestment in prevention
8 June 2026
…prevention, political and budgetary short-termism, misaligned incentives, and challenges of invisibility and attribution. Protecting, growing and diversifying funding sources can address key challenges; more innovative approaches can overcome multiple barriers…
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
Join OHE at ISPOR to discuss multiple criteria decision analysis, value based pricing, risk sharing, post-approval data collection and other key topics in HTA and health care decision making. The…
The New NHS: What Can We Learn From Managed Care in New Zealand and the US?
1 July 1999
…development of multipractice and multi-professional groups in primary care settings. • International learning… • The integration of health care is the defining theme of policy developments in the UK, US…